Results 171 to 180 of about 10,994 (215)
A placebo-controlled, crossover trial to investigate the efficacy of tiotropium bromide or placebo added to usual care in stable symptomatic post-hematopoietic stem cell transplantation (HSCT) bronchiolitis obliterans syndrome (BOS). [PDF]
TrialsDini N +6 more
europepmc +1 more source
A review of the therapeutic potential of the cysteinyl leukotriene antagonist Montelukast in the treatment of bronchiolitis obliterans syndrome following lung and hematopoietic-stem cell transplantation and its possible mechanisms. [PDF]
Ther Adv Respir DisKordjazy N, Amini S.
europepmc +1 more source
[Risk factors for the occurrence of bronchiolitis obliterans in children with refractory Mycoplasma pneumoniae pneumonia and the predictive value of the factors]. [PDF]
Zhongguo Dang Dai Er Ke Za ZhiCheng GL, Xu BX, Jia L.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Clinical Reviews in Allergy & Immunology, 2003
Bronchiolitis obliterans (BO) is a disease of small airways that results in progressive dyspnea and airflow limitation. It is a common sequela of bone marrow, lung, and heart-lung transplantation, but can also occur as a complication of certain pulmonary infections, adverse drug reaction, toxic inhalation, and autoimmune disorders.
Petey Laohaburanakit +2 more
openaire +3 more sources
Bronchiolitis obliterans (BO) is a disease of small airways that results in progressive dyspnea and airflow limitation. It is a common sequela of bone marrow, lung, and heart-lung transplantation, but can also occur as a complication of certain pulmonary infections, adverse drug reaction, toxic inhalation, and autoimmune disorders.
Petey Laohaburanakit +2 more
openaire +3 more sources
Seminars in Respiratory and Critical Care Medicine, 2000
Bronchiolitis obliterans (BO) is a fibrotic lung disease involving the small conducting airways. BO may be classified by etiology and underlying disease or, more commonly, by histopathological pattern. The two major histopathological categories are (1) BO organizing pneumonia (BOOP) and proliferative bronchiolitis and (2) constrictive bronchiolitis ...
L, Angel, A, Homma, S M, Levine
openaire +2 more sources
Bronchiolitis obliterans (BO) is a fibrotic lung disease involving the small conducting airways. BO may be classified by etiology and underlying disease or, more commonly, by histopathological pattern. The two major histopathological categories are (1) BO organizing pneumonia (BOOP) and proliferative bronchiolitis and (2) constrictive bronchiolitis ...
L, Angel, A, Homma, S M, Levine
openaire +2 more sources
Clinical Pediatrics, 1975
A case of severe, probably viral pneumonitis in a three-year-old child is presented, which resulted in complete atelectasis of the left lung, and in diffuse changes of bronchiolitis and bronchitis obliterans. The case represents a variant of bronchiolitis obliterans.
H, Azizirad +3 more
openaire +2 more sources
A case of severe, probably viral pneumonitis in a three-year-old child is presented, which resulted in complete atelectasis of the left lung, and in diffuse changes of bronchiolitis and bronchitis obliterans. The case represents a variant of bronchiolitis obliterans.
H, Azizirad +3 more
openaire +2 more sources
Current Opinion in Pulmonary Medicine, 2004
Bronchiolitis obliterans (BO) occurs in both post-lung transplant and nontransplant-related individuals, and is characterized by mainly irreversible airflow obstruction that is often ultimately progressive.While post-lung transplant BO is a major cause of lung allograft dysfunction, and hence is better characterized than nontransplant-related BO, it is
Roblee P Allen, Andrew L. Chan
openaire +3 more sources
Bronchiolitis obliterans (BO) occurs in both post-lung transplant and nontransplant-related individuals, and is characterized by mainly irreversible airflow obstruction that is often ultimately progressive.While post-lung transplant BO is a major cause of lung allograft dysfunction, and hence is better characterized than nontransplant-related BO, it is
Roblee P Allen, Andrew L. Chan
openaire +3 more sources